Precision BioSciences
DTIL
DTIL
152 hedge funds and large institutions have $96.6M invested in Precision BioSciences in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.02% less ownership
Funds ownership: 1.73% → 1.71% (-0.02%)
59% less capital invested
Capital invested by funds: $233M → $96.6M (-$137M)
Holders
152
Holding in Top 10
1
Calls
$54K
Puts
$51K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.1M | |
| 3 | +$1.06M | |
| 4 |
HF
HRT Financial
New York
|
+$715K |
| 5 |
Two Sigma Investments
New York
|
+$698K |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$4.68M | |
| 3 | -$3.84M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.9M |
| 5 |
Rafferty Asset Management
New York
|
-$1.19M |